 Isradipine overall clinical experience hypertension United Isradipine new dihydropyridine calcium antagonist efficacious safe treatment hypertension patient age race evidence negative inotropism atrioventricular conduction delay significant changes laboratory parameters isradipine treatment total patients isradipine double-blind hypertension trials patients placebo active controls hydrochlorothiazide enalapril mean changes baseline diastolic systolic blood pressures percentage patients treatment blood pressure decrease mm Hg isradipine placebo active controls Blood pressure response increases isradipine mg doses average result blood pressure reduction incidence adverse reactions isradipine similar active controls placebo discontinuations isradipine addition decrease incidence new adverse reactions duration treatment months